Alternative to Warfarin for Arrhythmia Greensboro NC

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study. Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity.

Edmund Joseph Le Bauer, MD
(336) 547-1752
PO Box 26201
Greensboro, NC
Specialties
Cardiology, Internal Medicine
Gender
Male
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1960
Hospital
Hospital: Moses H Cone Memorial Hospital, Greensboro, Nc
Group Practice: Lebauer Health Care

Data Provided by:
Thomas Andrew Brackbill, MD
(336) 272-6133
1002 N Church St Ste 103
Greensboro, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Columbia Univ Coll Of Physicians And Surgeons, New York Ny 10032
Graduation Year: 1968

Data Provided by:
Michael D Cooper
(336) 547-1752
1126 N Church St
Greensboro, NC
Specialty
Cardiovascular Disease

Data Provided by:
Dr.Stanley Tennant
(336) 272-6133
1002 N Church St # 103
Greensboro, NC
Gender
M
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ
Year of Graduation: 1978
Speciality
Cardiologist
General Information
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 1, reviews.

Data Provided by:
Jerome O Spruill, MD
(336) 273-6911
1307 N Elm St
Greensboro, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Meharry Med Coll Sch Of Med, Nashville Tn 37208
Graduation Year: 1979

Data Provided by:
Dr.Jeffrey Katz
(336) 547-1700
1126 North Church Street #101
Greensboro, NC
Gender
M
Education
Medical School: Univ Of Pa Sch Of Med
Year of Graduation: 1976
Speciality
Cardiologist
General Information
Hospital: Moses H Cone Memorial Hospital, Greensboro, Nc
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 1, reviews.

Data Provided by:
Jagadeesh R Ganji, MD
(336) 273-7900
1331 N Elm St
Greensboro, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Jjm Med Coll, Mysore Univ, Davangere, Karnataka, India
Graduation Year: 1990
Hospital
Hospital: Gaston Memorial Hospital, Gastonia, Nc
Group Practice: Mid Carolina Cardiology

Data Provided by:
Mohan Nenumal Harwani, MD
110 E Northwood St
Greensboro, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Indira Ghandi Med Coll, Nagpur Univ, Nagpur, Maharashtra, India
Graduation Year: 1982

Data Provided by:
Thomas David Stuckey
(336) 547-1700
1126 N Church St
Greensboro, NC
Specialty
Cardiology, Cardiovascular Disease

Data Provided by:
Robert Mitchell Rothbart, MD
(336) 547-1715
520 N Elam Ave
Greensboro, NC
Specialties
Cardiology, Internal Medicine
Gender
Male
Education
Medical School: Yale Univ Sch Of Med, New Haven Ct 06510
Graduation Year: 1978

Data Provided by:
Data Provided by:

Alternative to Warfarin for Arrhythmia

Provided By:

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study.

Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity. More than 90 percent of atrial blood clots in people with non-valvular atrial fibrillation may originate in the LAA, according to background information in the study.

The study included 463 people who underwent percutaneous implantation of a device, known as the Watchman, to close off the LAA. Their outcomes were compared with those of 244 people who continued long-term treatment with warfarin.

The researchers determined the effectiveness of the treatments by assessing the occurrence, during an average follow-up of 18 months, of strokes, death from cardiovascular causes and systemic embolisms (blood clots that go somewhere other than the brain). They also totaled the occurrence of such serious problems as major bleeding, pericardial effusion (accidental puncture of the heart causing fluid collection in the heart sac) and clots caused by the implanted device.

After 1,065 patient-years of follow-up, there were 3.0 such occurrences per 100 patient-years among those who'd had the device implanted, compared with 4.9 in the warfarin group, for a risk reduction of 38 percent. But people in the device group had more serious safety events -- 7.4 events per 100 patient-years versus 4.4 events in the warfarin group, the researchers found.

"The efficacy of percutaneous closure of the LAA with this device was non-inferior to that of warfarin therapy," concluded Dr. David R. Holmes, of the Mayo Clinic in Rochester, Minn., and his colleagues. "Although there was a higher rate of adverse safety events in the intervention group than the control group, events in the intervention group were mainly a result of periprocedural complications," they wrote.

"Closure of the LAA might provide an alternative strategy to chronic warfarin therapy for stroke prophylaxis in patients with non-valvular atrial fibrillation," they added.

The study appears this week in The Lancet.

More information

The American Academy of Family Physicians has more about atrial fibrillation.

SOURCE: The Lancet, news release, Aug. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com